Slovenian startup TK Analytics develops an advanced cell painting analysis platform CellusAI that refines and accelerates drug discovery using detailed information from cell painting images. The platform offers image segmentation, phenotyping, and prediction of molecular bioactivity and toxicity with a New Molecule Generative AI module, which generates chemical structures to induce specific cell painting profiles.